
AKTS
Healthcare · Biotechnology · $927.4M market cap
$16.62+0.34 (+2.1%)Nov 13, 4:00 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -14.2% over 90 days · 30-day revisions 2 up, 1 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Before the open | -0.47 | -0.54 | -14.9% |
| Aug 13, 2026 | After the close | -0.44 | -0.44 | 0.0% |
| May 11, 2026 | After the close | -0.33 | -0.38 | -15.2% |
| Feb 25, 2026 | Time not confirmed | -1.15 | -0.28 | +75.3% |
| Dec 19, 2025 | Time not confirmed | — | -16.06 | — |
| Nov 14, 2024 | Before the open | -0.08 | -0.04 | +50.0% |
| May 13, 2024 | Before the open | -0.12 | -0.14 | -16.7% |
| Feb 13, 2024 | Before the open | -0.18 | -0.19 | -5.6% |
| Nov 13, 2023 | Before the open | -0.18 | -0.27 | -50.0% |
| May 8, 2023 | Before the open | -0.21 | -0.20 | +4.8% |
| Feb 7, 2023 | Before the open | -0.25 | -0.19 | +24.0% |
| Nov 14, 2022 | Before the open | -0.23 | -0.28 | -21.7% |
| May 2, 2022 | Before the open | -0.23 | -0.22 |
Aktis Oncology, Inc., a clinical-stage oncology company, engages in the research, development, and commercialization of targeted radiopharmaceuticals to treat various solid tumor cancers. The company's lead product candidate includes [225Ac]Ac-AKY-1189, a miniprotein radioconjugate platform which is in ongoing Phase 1b clinical trial for the treatment of Nectin-4 expressing solid tumors, including locally advanced…
| +4.3% |
| Jan 31, 2022 | Before the open | -0.23 | -0.23 | 0.0% |
| Nov 1, 2021 | Before the open | -0.19 | -0.21 | -10.5% |
| May 3, 2021 | Before the open | -0.21 | -0.15 | +28.6% |
| Feb 1, 2021 | Before the open | -0.20 | -0.22 | -10.0% |
| Oct 30, 2020 | After the close | -0.20 | -0.23 | -15.0% |
| May 1, 2020 | After the close | -0.21 | -0.21 | 0.0% |
| Jan 31, 2020 | After the close | -0.22 | -0.30 | -36.4% |
| Sep 13, 2019 | After the close | -0.24 | -0.18 | +25.0% |
| May 10, 2019 | After the close | -0.22 | -0.31 | -40.9% |
| Feb 4, 2019 | After the close | -0.23 | -0.24 | -4.3% |
| Nov 5, 2018 | Before the open | -0.23 | -0.33 | -43.5% |
| May 15, 2018 | Before the open | -0.23 | -0.19 | +17.4% |
| Feb 14, 2018 | After the close | -0.18 | -0.20 | -11.1% |